🔧 Filters
Try: author name · keyword phrase · DOI
Original Article
Background: Dyslipidemia, characterized by abnormal blood lipid levels, is a major risk factor for cardiovascular disease, contributing to an estimated 4.2 million deaths and disabilities globally. Th
CholesterolDyslipidemiaHDLLDLLipid ProfileTriglycerides
Original Article
Introduction: Pediatric metabolic screening is governed by a weight-centric dualism that prioritizes obesity while overlooking cardiometabolic risks in undernutrition. While obesity-related dyslipidem
Pediatric ObesityGrowth DisordersDyslipidemiasChild Health Services.
Original Article
Introduction: Lipoprotein(a) is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD). Despite known ethnic differences, Lp(a) data among UK Black popul
Lipoprotein(a)Point-of-care testingCardiovascular risk stratificationBlack populationAtherosclerotic cardiovascular disease. Community screening.
Original Article
Background: Although statins remain the cornerstone of lipid-lowering therapy, LDL-C targets are often not achieved with statin monotherapy. This study evaluated the effectiveness and tolerability of
Dyslipidemialow-density lipoprotein cholesterolrosuvastatinezetimibecombination therapyatherosclerotic cardiovascular disease.